MYCOPHENOLATE Drug Patent Profile
✉ Email this page to a colleague
When do Mycophenolate patents expire, and what generic alternatives are available?
Mycophenolate is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Apotex Corp, Aurobindo Pharma Ltd, Concord Biotech Ltd, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Hikma, Jubilant Cadista, Mylan, Sandoz, Strides Pharma, Strides Pharma Intl, Teva Pharms, Wuxi, Zhejiang Hisun Pharm, Zydus Pharms Usa Inc, Amneal, Lannett Co Inc, Rising, Teva Pharms Usa, Vistapharm Llc, Apotex, Aurobindo Pharma, Bpi Labs, Meitheal, Mylan Labs Ltd, Onesource Specialty, Ph Health, Zydus Pharms, Apotex Inc, Biocon Pharma, Fosun Wanbang, Rk Pharma, Twi Pharms, and Yichang Humanwell. and is included in sixty-one NDAs.
The generic ingredient in MYCOPHENOLATE is mycophenolate sodium. There are thirty-eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mycophenolate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mycophenolate
A generic version of MYCOPHENOLATE was approved as mycophenolate sodium by APOTEX INC on August 21st, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MYCOPHENOLATE?
- What are the global sales for MYCOPHENOLATE?
- What is Average Wholesale Price for MYCOPHENOLATE?
Summary for MYCOPHENOLATE
| US Patents: | 0 |
| Applicants: | 36 |
| NDAs: | 61 |
| Drug Prices: | Drug price information for MYCOPHENOLATE |
| DailyMed Link: | MYCOPHENOLATE at DailyMed |
US Patents and Regulatory Information for MYCOPHENOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yichang Humanwell | MYCOPHENOLATE SODIUM | mycophenolate sodium | TABLET, DELAYED RELEASE;ORAL | 214376-001 | Feb 10, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Pharms Usa Inc | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 065477-001 | May 4, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys Labs Ltd | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 090464-001 | Sep 13, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zydus Pharms | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 204473-001 | Aug 31, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Biocon Pharma | MYCOPHENOLATE SODIUM | mycophenolate sodium | TABLET, DELAYED RELEASE;ORAL | 214630-002 | Nov 29, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
